14th International Congress on Targeted Anticancer Therapies

This event qualifies for 18 AMA PRA Category 1 Credits

TAT congresses are annual meetings on new molecular targets and innovative cancer therapeutics in the early phases of clinical development, supplemented by associated translational research. Add to these features the high scientific standards, informal atmosphere, and active participation by the world’s leading phase 1 investigators, and you will understand why the TAT Congress series has become the prime international drug development meeting in oncology.

“The home of phase 1 in oncology”

TAT Congresses are more than regular meetings of drug development professionals from academia and pharma and biotech industry. They are the place where the world’s leaders in early-phase development of new cancer therapeutics gather annually, establish and re-new professional and personal relationships, exchange views, discuss matters of common interest, and establish new collaborations.